Marker Therapeutics Inc (MRKR)
4.11
+0.06
(+1.48%)
USD |
NASDAQ |
May 01, 16:00
4.10
-0.01
(-0.24%)
Pre-Market: 20:00
Marker Therapeutics Max Drawdown (5Y): 99.42% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.42% |
| March 31, 2024 | 99.42% |
| February 29, 2024 | 99.42% |
| January 31, 2024 | 99.42% |
| December 31, 2023 | 99.42% |
| November 30, 2023 | 99.42% |
| October 31, 2023 | 99.42% |
| September 30, 2023 | 99.42% |
| August 31, 2023 | 99.42% |
| July 31, 2023 | 99.42% |
| June 30, 2023 | 99.42% |
| May 31, 2023 | 99.42% |
| April 30, 2023 | 99.42% |
| March 31, 2023 | 99.42% |
| February 28, 2023 | 98.32% |
| January 31, 2023 | 98.05% |
| December 31, 2022 | 98.05% |
| November 30, 2022 | 97.89% |
| October 31, 2022 | 97.89% |
| September 30, 2022 | 98.19% |
| August 31, 2022 | 98.62% |
| July 31, 2022 | 98.62% |
| June 30, 2022 | 98.62% |
| May 31, 2022 | 98.62% |
| April 30, 2022 | 98.62% |
| Date | Value |
|---|---|
| March 31, 2022 | 98.62% |
| February 28, 2022 | 98.62% |
| January 31, 2022 | 98.62% |
| December 31, 2021 | 98.62% |
| November 30, 2021 | 98.67% |
| October 31, 2021 | 98.77% |
| September 30, 2021 | 98.80% |
| August 31, 2021 | 98.80% |
| July 31, 2021 | 98.80% |
| June 30, 2021 | 98.80% |
| May 31, 2021 | 98.80% |
| April 30, 2021 | 98.80% |
| March 31, 2021 | 98.80% |
| February 28, 2021 | 98.80% |
| January 31, 2021 | 98.80% |
| December 31, 2020 | 98.80% |
| November 30, 2020 | 98.80% |
| October 31, 2020 | 98.80% |
| September 30, 2020 | 98.80% |
| August 31, 2020 | 98.80% |
| July 31, 2020 | 98.80% |
| June 30, 2020 | 99.01% |
| May 31, 2020 | 99.01% |
| April 30, 2020 | 99.01% |
| March 31, 2020 | 99.01% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.89%
Minimum
Oct 2022
99.65%
Maximum
May 2019
98.99%
Average
98.80%
Median
Jul 2020
Max Drawdown (5Y) Benchmarks
| AIM ImmunoTech Inc | 99.76% |
| Perspective Therapeutics Inc | 91.70% |
| Protalix BioTherapeutics Inc | 94.35% |
| Electromed Inc | 55.84% |
| Armata Pharmaceuticals Inc | 99.87% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -59.34 |
| Beta (5Y) | 1.537 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 119.1% |
| Historical Sharpe Ratio (5Y) | -0.3544 |
| Historical Sortino (5Y) | -0.9444 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 39.49% |